Principal Financial Group’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.4K | Sell |
10,808
-720
| -6% | -$2.23K | ﹤0.01% | 2203 |
|
|
2025
Q1 | $40.2K | Sell |
11,528
-1,288
| -10% | -$4.5K | ﹤0.01% | 2128 |
|
|
2024
Q4 | $41.9K | Sell |
12,816
-939
| -7% | -$3.07K | ﹤0.01% | 2175 |
|
|
2024
Q3 | $53K | Sell |
13,755
-12,352
| -47% | -$47.6K | ﹤0.01% | 2174 |
|
|
2024
Q2 | $80.7K | Sell |
26,107
-15,341
| -37% | -$47.4K | ﹤0.01% | 2240 |
|
|
2024
Q1 | $107K | Sell |
41,448
-4,127
| -9% | -$10.6K | ﹤0.01% | 2266 |
|
|
2023
Q4 | $114K | Sell |
45,575
-25
| -0.1% | -$63 | ﹤0.01% | 2251 |
|
|
2023
Q3 | $92.6K | Buy |
45,600
+3,915
| +9% | +$7.95K | ﹤0.01% | 2294 |
|
|
2023
Q2 | $95.9K | Buy |
41,685
+2,603
| +7% | +$5.99K | ﹤0.01% | 2296 |
|
|
2023
Q1 | $118K | Buy |
39,082
+251
| +0.6% | +$761 | ﹤0.01% | 2277 |
|
|
2022
Q4 | $90.5K | Buy |
38,831
+24,800
| +177% | +$57.8K | ﹤0.01% | 2308 |
|
|
2022
Q3 | $27K | Buy |
14,031
+2,191
| +19% | +$4.22K | ﹤0.01% | 2443 |
|
|
2022
Q2 | $32K | Buy |
+11,840
| New | +$32K | ﹤0.01% | 2481 |
|